Viking Therapeutics, Inc. (VKTX): SCHEDULE 13G/A filed Nov 5, 2026

Form type

SCHEDULE 13G/A

Filing date

Nov 5, 2026

Accession number

0000315066-26-002856

Filer

Viking Therapeutics, Inc. (CIK 1607678)